Literature DB >> 31236749

Criminal Justice System Involvement as a Risk Factor for Detectable Plasma HIV Viral Load in People Who Use Illicit Drugs: A Longitudinal Cohort Study.

Sarah Ickowicz1, N A Mohd Salleh1,2, Nadia Fairbairn1,3, Lindsey Richardson1,4, Will Small1,5, M-J Milloy6,7.   

Abstract

Among HIV-positive people who use illicit drugs (PWUD) in our setting, repeated periods of incarceration adversely affect ART adherence in a dose-dependent manner. However, the impact of non-custodial criminal justice involvement on HIV-related outcomes has not been previously investigated. Data were obtained from a longitudinal cohort of HIV-positive PWUD in a setting of universal no-cost ART and complete dispensation records. Multivariate generalized estimating equations were used to calculate the longitudinal odds of having a detectable HIV VL (VL) associated with custodial and non-custodial CJS exposure. Between 2005 and 2014, 716 HIV-positive ART-exposed PWUD were recruited. In multivariate analysis, both custodial [Adjusted odds ratio (AOR) 0.61, 95% CI 0.45-0.82] and noncustodial (AOR 0.78, 95% CI 0.62-0.99) involvement in the criminal justice system was associated with detectable HIV VL. Among HIV-positive PWUD, both custodial and non-custodial criminal justice involvement is associated with worse HIV treatment outcomes. Our findings highlight the need for increased ART adherence support across the full spectrum of the criminal justice system.

Entities:  

Keywords:  Anti-HIV agents; Antiretroviral therapy; HIV infections; Prisons; Substance abuse

Mesh:

Substances:

Year:  2019        PMID: 31236749      PMCID: PMC6773261          DOI: 10.1007/s10461-019-02547-z

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  38 in total

1.  Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.

Authors:  Jaimie P Meyer; Javier Cepeda; Johnny Wu; Robert L Trestman; Frederick L Altice; Sandra A Springer
Journal:  JAMA Intern Med       Date:  2014-05       Impact factor: 21.873

2.  Housing instability among people who inject drugs: results from the Australian needle and syringe program survey.

Authors:  Libby Topp; Jenny Iversen; Eileen Baldry; Lisa Maher
Journal:  J Urban Health       Date:  2013-08       Impact factor: 3.671

3.  Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users.

Authors:  M J Milloy; Thomas Kerr; Jane Buxton; Tim Rhodes; Silvia Guillemi; Robert Hogg; Julio Montaner; Evan Wood
Journal:  J Infect Dis       Date:  2011-05-01       Impact factor: 5.226

4.  Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.

Authors:  Brenden Joseph; Thomas Kerr; Cathy M Puskas; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Care       Date:  2015-04-27

5.  Barriers to use of free antiretroviral therapy in injection drug users.

Authors:  S A Strathdee; A Palepu; P G Cornelisse; B Yip; M V O'Shaughnessy; J S Montaner; M T Schechter; R S Hogg
Journal:  JAMA       Date:  1998-08-12       Impact factor: 56.272

6.  Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.

Authors:  Sandra Ann Springer; Shu Chen; Frederick L Altice
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

7.  Alcohol use and incarceration adversely affect HIV-1 RNA suppression among injection drug users starting antiretroviral therapy.

Authors:  Anita Palepu; Mark W Tyndall; Kathy Li; Benita Yip; Michael V O'Shaughnessy; Martin T Schechter; Julio S G Montaner; Robert S Hogg
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

Review 8.  Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugs.

Authors:  Surita Parashar; Alexandra B Collins; Julio S G Montaner; Robert S Hogg; Michael-John Milloy
Journal:  Curr Opin HIV AIDS       Date:  2016-09       Impact factor: 4.283

9.  The impact of incarceration upon adherence to HIV treatment among HIV-positive injection drug users: a qualitative study.

Authors:  Will Small; Evan Wood; Glenn Betteridge; Julio Montaner; Thomas Kerr
Journal:  AIDS Care       Date:  2009-06

10.  Plasma HIV-1 RNA viral load rebound among people who inject drugs receiving antiretroviral therapy (ART) in a Canadian setting: an ethno-epidemiological study.

Authors:  Will Small; M J Milloy; Ryan McNeil; Lisa Maher; Thomas Kerr
Journal:  AIDS Res Ther       Date:  2016-07-25       Impact factor: 2.250

View more
  2 in total

1.  Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 - is the precautionary principle applicable?

Authors:  Lucas Wiessing; Eleni Kalamara; Jack Stone; Peyman Altan; Luk Van Baelen; Anastasios Fotiou; D'Jamila Garcia; Joao Goulao; Bruno Guarita; Vivian Hope; Marie Jauffret-Roustide; Lina Jurgelaitienė; Martin Kåberg; Adeeba Kamarulzaman; Liis Lemsalu; Anda Kivite-Urtane; Branko Kolarić; Linda Montanari; Magdalena Rosińska; Lavinius Sava; Ilonka Horváth; Thomas Seyler; Vana Sypsa; Anna Tarján; Ioanna Yiasemi; Ruth Zimmermann; Marica Ferri; Kate Dolan; Anneli Uusküla; Peter Vickerman
Journal:  Euro Surveill       Date:  2021-12

2.  The state of harm reduction in prisons in 30 European countries with a focus on people who inject drugs and infectious diseases.

Authors:  Heino Stöver; Anna Tarján; Gergely Horváth; Linda Montanari
Journal:  Harm Reduct J       Date:  2021-06-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.